Tapinarof Under FDA Review for Treating Atopic Dermatitis Tapinarof Under FDA Review for Treating Atopic Dermatitis

Approved in 2022 for psoriasis, the manufacturer has submitted an application for approval of tapinarof cream for treating atopic dermatitis in adults and children 2 years of age and older.MDedge News

Source: Medscape Allergy Headlines - February 16, 2024 Category: Allergy & Immunology Tags: Dermatology Source Type: news